Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Dana-Farber Cancer Institute, Boston, Massachusetts Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio Oregon Health and Science University, Portland, Oregon M D Anderson Cancer Center, Houston, Texas